名称 | Corrigendum to “Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats” [Life Sci. 224 (2019) 177–186](S002432051930027X)(10.1016/j.lfs.2019.01.017) |
作者 | |
发表期刊 | Life Sciences; |
语种 | 英语 |
原始文献类型 | Erratum |
摘要 | The authors regret errors present in Fig. 1. The image of Iso group in Fig. 1A was incorrect. In Fig. 1B, the histogram order of Iso + SP and Iso + SP + ZM groups in cardiac function was incorrect. The revised figure is shown below. The correction does not affect the conclusions of the original article. The authors would like to apologize for any inconvenience caused. The corrected figure is provided below: [Figure presented] |
出版者 | PERGAMON-ELSEVIER SCIENCE LTD |
ISSN | 0024-3205 |
EISSN | 1879-0631 |
卷号 | 298 |
DOI | 10.1016/j.lfs.2022.120430 |
页数 | 2 |
WOS类目 | Medicine, Research & Experimental ; Pharmacology & Pharmacy |
WOS研究方向 | Research & Experimental Medicine ; Pharmacology & Pharmacy |
WOS记录号 | WOS:000797029000001 |
收录类别 | SCOPUS ; SCIE |
发布日期 | 2022-06-01 |
URL | 查看原文 |
PubMed ID | 35379487 |
通讯作者地址 | [Zhou, Hao;Zhou, Hao]Wenzhou Med Univ, Dept Cardiol, Affiliated Hosp 1, Wenzhou 325000, Peoples R China. ; [Gong, Yongsheng]Wenzhou Med Univ, Dept Hypoxia Med Res Lab, Wenzhou 325000, Peoples R China. |
Scopus学科分类 | Biochemistry, Genetics and Molecular Biology (all);Pharmacology, Toxicology and Pharmaceutics (all) |
SCOPUSEID | SCOPUS_ID:85127485268 |
TOP期刊 | TOP期刊 |
引用统计 | |
文献类型 | 其他 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/184748 |
专题 | 附属第一医院 温州医科大学 |
通讯作者 | Gong, Yongsheng; Zhou, Hao |
作者单位 | 1.Wenzhou Med Univ, Dept Cardiol, Affiliated Hosp 1, Wenzhou 325000, Peoples R China; 2.Xi An Jiao Tong Univ, Stomatol Hosp, Coll Med, Xi'an 710004, Peoples R China; 3.Wenzhou Cent Hosp, Dept Clin Lab, Wenzhou 325000, Peoples R China; 4.Wenzhou Med Univ, Dept Hypoxia Med Res Lab, Wenzhou 325000, Peoples R China |
第一作者单位 | 附属第一医院 |
通讯作者单位 | 附属第一医院; 温州医科大学 |
推荐引用方式 GB/T 7714 | Chen, Xingxing,Ge, Wenhua,Dong, Tiancheng,et al. Corrigendum to “Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats” [Life Sci. 224 (2019) 177–186](S002432051930027X)(10.1016/j.lfs.2019.01.017). 2022. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论